Anic Equity¶
'#---------------------------------------------------------#'
Total return since start: 0.713 %¶
'#---------------------------------------------------------#'
Equity now: -----------------------------> 52312.05 Kr¶
Max Equity ever reached: ------------> 53120.35 Kr¶
Portfolio value: --------------------------> 45977.02 Kr¶
PnL: ---------------------------------------> -775.98 Kr¶
DD now: ---------------------------------> -1.522 %¶
Max portfolio DD since start: ----> -13.025 %¶
Updated:¶
'2023-06-13 10:31:24.721087'
Anic Portfolio Holdings¶
| volume | changePercent | value | profit | profitPercent | acquiredValue | |
|---|---|---|---|---|---|---|
| name | ||||||
| Nederman Holding | 11 | 3.400000 | 2343.000000 | 154.000000 | 7.040000 | 2189.000000 |
| Embracer Group B | 26 | 4.320000 | 703.170000 | 41.170000 | 6.220000 | 661.999988 |
| BHG Group | 49 | -2.390000 | 680.120000 | 41.120000 | 6.440000 | 638.999984 |
| Vitrolife | 3 | 3.910000 | 702.000000 | 25.000000 | 3.690000 | 677.000001 |
| Biotage | 4 | 0.710000 | 622.800000 | 19.800000 | 3.280000 | 603.000000 |
| Indutrade | 5 | 2.060000 | 1337.500000 | 17.500000 | 1.330000 | 1320.000000 |
| Addtech B | 3 | 1.710000 | 715.200000 | 15.200000 | 2.170000 | 699.999999 |
| Eastnine | 6 | -2.610000 | 672.000000 | 15.000000 | 2.280000 | 657.000000 |
| Addnode Group B | 6 | 2.320000 | 766.800000 | 14.800000 | 1.970000 | 751.999998 |
| SynAct Pharma | 9 | -2.400000 | 657.900000 | 12.900000 | 2.000000 | 645.000003 |
| Xvivo Perfusion | 3 | 0.000000 | 856.500000 | 11.500000 | 1.360000 | 845.000001 |
| Sdiptech B | 3 | 0.290000 | 831.600000 | 9.600000 | 1.170000 | 822.000000 |
| Nolato B | 12 | -0.270000 | 656.400000 | 8.400000 | 1.300000 | 648.000000 |
| BONESUPPORT HOLDING | 10 | -0.240000 | 1230.000000 | 6.000000 | 0.490000 | 1224.000000 |
| NCC B | 7 | 0.160000 | 659.750000 | 5.750000 | 0.880000 | 653.999997 |
| Latour B | 2 | 1.390000 | 452.200000 | 3.200000 | 0.710000 | 449.000000 |
| Fortnox | 10 | 3.520000 | 669.800000 | 1.800000 | 0.270000 | 668.000000 |
| Sedana Medical | 135 | -2.250000 | 4330.800000 | -0.200000 | 0.000000 | 4330.999935 |
| Profoto Holding | 7 | 0.000000 | 581.000000 | -1.000000 | -0.170000 | 581.999999 |
| NCC A | 6 | 1.630000 | 597.600000 | -1.400000 | -0.230000 | 598.999998 |
| Lime Technologies | 2 | -1.180000 | 587.000000 | -6.000000 | -1.010000 | 593.000000 |
| Volati | 5 | -4.550000 | 566.000000 | -8.000000 | -1.390000 | 574.000000 |
| Sampo Oyj SDB | 1 | -1.100000 | 496.500000 | -8.500000 | -1.680000 | 505.000000 |
| Investor B | 3 | 0.560000 | 649.200000 | -8.800000 | -1.340000 | 657.999999 |
| SCA A | 4 | -0.270000 | 588.800000 | -10.200000 | -1.700000 | 599.000000 |
| Balco Group | 39 | 0.000000 | 1860.300000 | -14.700000 | -0.780000 | 1874.999997 |
| Humana | 40 | 0.000000 | 643.200000 | -30.800000 | -4.570000 | 674.000000 |
| Lundin Gold | 7 | 1.380000 | 922.600000 | -51.400000 | -5.280000 | 973.999999 |
| Ambea | 68 | 0.830000 | 2479.280000 | -57.720000 | -2.280000 | 2537.000032 |
| Creades A | 7 | 1.030000 | 547.400000 | -63.600000 | -10.410000 | 610.999998 |
| Investor A | 16 | 0.420000 | 3470.400000 | -74.600000 | -2.100000 | 3545.000000 |
| New Wave B | 40 | 0.210000 | 3826.800000 | -89.200000 | -2.280000 | 3916.000000 |
| Gaming Innovation Group | 161 | -0.400000 | 4025.000000 | -163.000000 | -3.890000 | 4187.999942 |
| Wästbygg Gruppen B | 80 | -1.470000 | 2688.000000 | -183.000000 | -6.370000 | 2871.000000 |
| Bactiguard Holding B | 37 | -3.760000 | 2560.400000 | -406.600000 | -13.700000 | 2966.999993 |
| TOTAL | 45977.020000 | -775.980000 | -1.52164% | 46752.999863 |
Updated:¶
'2023-06-13 10:31:41.999457'
None
Last optimization/rebalancing:¶
'2023-05-05'
Next optimization/rebalancing:¶
'2023-06-15'
AVAN-Live vs backtest and OMXSE30 2023¶
Walk forward test results - depending on starting day¶
Equity is shown as log of returns. Returns range by a factor of 10. Best is about 10000%, 100 times money, and worst 1000%, 10 times money in 20 years. Maximal duration for drawdown periods vary between 280-750 days. Worst drawdown across the tests is about 40 %. ¶
